Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Mylan announced the launch of Lamivudine and Zidovudine Tablets, the generic version of ViiV’s Combivir.
Combivir is indicated for the treatment of HIV-1 infection in combination with other antiretroviral drugs. Lamivudine is phosphorylated to its active 5′-triphosphate metabolite, lamivudine triphosphate (3TC-TP). Zidovudine is phosphorylated to its active 5′-triphosphate metabolite, zidovudine triphosphate (ZDV-TP). The principal mode of action of 3TC-TP and ZDV-TP is inhibition of reverse transcriptase (RT) via DNA chain termination after incorporation of the nucleotide analogue.
RELATED: Antiretroviral Treatments
Lamivudine and Zidovudine Tablets are available in 150mg/300mg tablets. Mylan has begun shipping this product.
For more information call (800) RX-MYLAN or visit Mylan.com.
